Member Publications - September 2019

  1. NF-κB/NKILA signaling modulates the anti-cancerous effects of EZH2 inhibition. Duan S, Chan WK, Oman A, Basile DP, Alvira CM, Buxton ILO, Iosef C.J Cell Mol Med. 2019 Sep;23(9):6182-6192. doi: 10.1111/jcmm.14500. Epub 2019 Jul 7.